Terns Pharmaceuticals, Inc. short interest in 2026

In 2026, Terns Pharmaceuticals, Inc.'s disclosed short interest ran from 17.93% of shares outstanding on 15 Jan 2026 to 4.80% on 30 Apr 2026, a change of -13.13 percentage points. The year's high was 20.66% on 13 Feb 2026 and its low 4.80% on 30 Apr 2026, averaging 14.98% across 8 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 9.61 days on 13 Feb 2026. Full history: Terns Pharmaceuticals, Inc..

Cite this page

Plain

Short position data for Terns Pharmaceuticals, Inc. short interest in 2026: FINRA, compiled by howshorted.com, settlement date 30 Apr 2026. https://howshorted.com/us/company/tern-2026/2026/

Wikipedia

<ref>{{cite web |title=Terns Pharmaceuticals, Inc. short interest in 2026 short position data |url=https://howshorted.com/us/company/tern-2026/2026/ |website=HowShorted |publisher=howshorted.com (data: FINRA) |date=2026-04-30 |access-date=2026-10-13}}</ref>

BibTeX

@misc{howshorted-terns-pharmaceuticals-inc-short-interest-2026-04-30,
  title        = {Terns Pharmaceuticals, Inc. short interest in 2026 short position data},
  author       = {{HowShorted}},
  howpublished = {\url{https://howshorted.com/us/company/tern-2026/2026/}},
  note         = {Data: FINRA, settlement date 30 Apr 2026; accessed 2026-10-13},
  year         = {2026}
}

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

2026 in figures

Start of year: 17.93% (15 Jan 2026)
End of year: 4.80% (30 Apr 2026)
Change: -13.13 pp
High: 20.66% (13 Feb 2026)
Low: 4.80% (30 Apr 2026)
Average: 14.98%
Highest days to cover: 9.61 (13 Feb 2026)
SEC filings marked: 2

Every report in 2026

Terns Pharmaceuticals, Inc. short interest in 2026
Settlement	Short interest	Days to cover	Filings since previous
15 Jan 2026	17.93%	6.36	results (8-K)
30 Jan 2026	19.14%	9.18
13 Feb 2026	20.66%	9.61
27 Feb 2026	18.45%	8.71
13 Mar 2026	20.20%	8.66
31 Mar 2026	11.70%	1.12	10-K filed
15 Apr 2026	6.98%	1.00
30 Apr 2026	4.80%	1.46

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.